Vita Coco Company, Inc. COCO
The Vita Coco Company pioneered packaged coconut water in 2004 and we have extended our business into other categories. Our mission is to deliver great tasting, natural and nutritious products that we believe are better for consumers and better for the world. We are one of the largest brands globally in the coconut and other plant waters category, and a large supplier of Private Label coconut water.
Our branded portfolio is led by our Vita Coco brand, which is the leader in the coconut water category in the United States, and also includes coconut oil, juice, and milk offerings. Our portfolio also includes PWR LIFT, a protein-infused fitness drink. We previously offered Runa, a plant-based energy drink inspired by the guayusa plant native to Ecuador, which we ceased selling in December 2023 and impaired all remaining assets in September 2025, and Ever & Ever, a sustainably packaged water, which we ceased producing in 2024. We supply Private Label products to key retailers in both the coconut water and coconut oil categories.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- United States
- All other countries
- United Kingdom
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $471.5M | $414.4M | $402.0M |
| All other countries | $71.5M | $48.4M | $47.3M |
| United Kingdom | $66.7M | $53.3M | $44.3M |
As the company reported it, from the “Segment Reporting - Net Revenues by Country (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $609.8M | $516.0M | $493.6M | $427.8M | $379.5M | $310.6M | $283.9M | — |
| Cost of revenue | $387.2M | $317.2M | $312.9M | $324.4M | $266.4M | $205.8M | $191.0M | — |
| Gross profit | $222.6M | $198.8M | $180.7M | $103.4M | $113.1M | $104.9M | $93.0M | — |
| R&D | $399.0K | $398.0K | $418.0K | $541.0K | $477.0K | $313.0K | $642.0K | — |
| SG&A | $140.1M | $125.0M | $124.2M | $100.3M | $88.6M | $74.4M | $78.9M | — |
| Total operating expenses | $140.1M | $125.0M | $124.2M | $100.3M | $88.6M | $58.0M | $79.6M | — |
| Operating income | $82.5M | $73.8M | $56.5M | $3.1M | $24.6M | $46.9M | $13.4M | — |
| Interest expense | — | $0 | $31.0K | $258.0K | $360.0K | $791.0K | $1.2M | — |
| Pre-tax income | $93.0M | $70.8M | $57.9M | $10.8M | $24.2M | $43.6M | $11.4M | — |
| Income tax | $21.7M | $14.8M | $11.3M | $3.0M | $5.2M | $10.9M | $2.0M | — |
| Net income | $72.7M | $56.0M | $46.6M | $7.8M | $19.0M | $32.7M | $9.4M | — |
| EPS, basic | 1.25 | 0.99 | 0.83 | 0.14 | 0.35 | 0.56 | 0.17 | — |
| EPS, diluted | 1.19 | 0.94 | 0.79 | 0.14 | 0.35 | 0.56 | 0.16 | — |
| Shares, diluted (wtd. avg.) | 60.0M | 59.3M | 58.7M | 56.1M | 54.2M | 58.6M | 57.2M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $196.9M | $164.7M | $132.9M | $19.6M | $28.7M | $72.2M | $36.7M | $25.5M |
| Receivables | $81.5M | $63.5M | $50.1M | $43.4M | $47.2M | $30.5M | — | — |
| Inventory | $111.5M | $83.6M | $50.8M | $84.1M | $75.4M | $32.0M | — | — |
| Total current assets | $421.4M | $341.3M | $262.9M | $174.9M | $173.3M | $159.1M | — | — |
| Property, plant and equipment | $9.3M | $2.4M | $2.1M | $2.1M | $2.5M | $2.9M | — | — |
| Goodwill | $7.8M | $7.8M | $7.8M | $7.8M | $7.8M | $7.8M | — | — |
| Other intangibles | — | — | $0 | $0 | $7.9M | $9.2M | — | — |
| Total assets | $461.2M | $362.4M | $285.7M | $197.8M | $197.5M | $183.9M | — | — |
| Accounts payable | $25.5M | $30.8M | $21.8M | $15.9M | $28.3M | $15.8M | — | — |
| Total current liabilities | $116.4M | $103.3M | $82.6M | $54.3M | $74.0M | $55.7M | — | — |
| Total liabilities | $129.6M | $103.6M | $83.2M | $56.7M | $74.3M | $81.6M | — | — |
| Retained earnings | $228.0M | $156.7M | $100.7M | $55.2M | $47.4M | $28.4M | — | — |
| Total equity | $331.5M | $258.8M | $202.4M | $141.1M | $123.2M | $102.3M | $73.8M | $61.3M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $47.2M | $42.9M | $107.2M | -$10.9M | -$16.2M | $33.3M | $21.8M | — |
| Depreciation and amortisation | $1.1M | $745.0K | $660.0K | $681.0K | $849.0K | $905.0K | $846.0K | — |
| Stock-based compensation | $10.8M | $8.9M | $9.1M | $7.4M | $3.4M | $1.5M | $2.2M | — |
| Capital expenditure | $8.1M | $974.0K | $599.0K | $982.0K | $557.0K | $392.0K | $1.0M | — |
| Investing cash flow | -$8.3M | -$974.0K | -$594.0K | -$982.0K | -$557.0K | -$375.0K | -$1.0M | — |
| Financing cash flow | -$7.5M | -$8.3M | $6.3M | $3.0M | -$26.8M | $2.0M | -$10.4M | — |
| Buybacks | $11.3M | $12.0M | $773.0K | $0 | $50.0M | $6.9M | $37.0K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001482981-26-000107.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $283.9M | $310.6M | $379.5M | $427.8M | $493.6M | $516.0M | $609.8M |
| Gross profit | — | $93.0M | $104.9M | $113.1M | $103.4M | $180.7M | $198.8M | $222.6M |
| Net income | — | $9.4M | $32.7M | $19.0M | $7.8M | $46.6M | $56.0M | $72.7M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Acquisition or disposal completed A purchase or sale of a significant business or asset has closed. Item 2.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Officer or director change Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 2080
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| KO | COCA COLA CO | $398.88B | 30.5x | 1.9% |
| PEP | PEPSICO INC | $185.31B | 22.6x | 2.3% |
| KDP | Keurig Dr Pepper Inc. | $47.19B | 22.7x | 8.2% |
| BF-B | BROWN FORMAN CORP | $13.49B | 19.2x | -1.2% |
| PRMB | Primo Brands Corp | $7.13B | 123.1x | 29.3% |
| BRCC | BRC Inc. | $1.33B | — | 1.7% |
| WEST | Westrock Coffee Co | $964.1M | — | 39.8% |
| BUDA | BUDA JUICE, INC. | $82.9M | 33.0x | 11.8% |